Key result
Factor VIII concentrates support surgical hemostasis in hemophilia, but bleeding occurred in ~29% of cases.
Case Report (n=5)
Answers are grounded in this paper and cite their sources.
Seven surgical procedures were successfully performed on five patients suffering from classic hemophilia. Hemostasis was maintained by the use of three factor VIII concentrates: cryoprecipitate, American National Red Cross high-purity concentrate, and a lyophilized glycine-precipitated fraction. Significant hemorrhage occurred twice, in each instance when the patient's factor VIII levels fell below 20% of normal. The availability of satisfactory concentrates of factor VIII permits consideration of elective surgical procedures in the hemophiliac. It should be emphasized, however, that such operations should be undertaken only if the indications are unequivocal and the necessary clinical and laboratory facilities are available.
No takes yet. Share an insight, caveat, or question.
Joseph J. Mazza (1970) conducted a case report in Classic hemophilia undergoing surgical procedures (n=5). Factor VIII concentrates (cryoprecipitate, American National Red Cross high-purity concentrate, lyophilized glycine-precipitated fraction) was evaluated on Significant hemorrhage during or after surgical procedures.
Synapse has enriched 10 related papers. Consider them for comparative context: